↓ Skip to main content

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19

Overview of attention for article published in Open Forum Infectious Diseases, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
18 X users
patent
1 patent

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19
Published in
Open Forum Infectious Diseases, December 2021
DOI 10.1093/ofid/ofab563
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 3 10%
Student > Bachelor 3 10%
Student > Master 3 10%
Student > Ph. D. Student 2 6%
Other 1 3%
Other 0 0%
Unknown 19 61%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 5 16%
Pharmacology, Toxicology and Pharmaceutical Science 4 13%
Environmental Science 1 3%
Business, Management and Accounting 1 3%
Engineering 1 3%
Other 0 0%
Unknown 19 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2024.
All research outputs
#3,497,078
of 34,329,868 outputs
Outputs from Open Forum Infectious Diseases
#1,618
of 6,932 outputs
Outputs of similar age
#64,625
of 563,627 outputs
Outputs of similar age from Open Forum Infectious Diseases
#57
of 246 outputs
Altmetric has tracked 34,329,868 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,932 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 563,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.